Literature DB >> 3087885

Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.

N Inagaki, S Goto, M Yamasaki, H Nagai, A Koda.   

Abstract

Several attempts were made to elucidate the possible role of histamine, serotonin, leukotrienes C4 (LTC4) and D4 (LTD4), and prostaglandin E1 (PGE1) as vascular permeability increasing factors involved in 48-hour homologous passive cutaneous anaphylaxis (PCA) in the mouse ear. Increased vascular permeability in the mouse ear caused by the mediator injection or PCA was assessed quantitatively by measuring the amount of extravasated dye. In skin reactions, all of the mediators used in the present study significantly increased vascular permeability. The most potent mediator was serotonin, which increased the vascular permeability from a concentration of 10(-8) g/ml, and the activity was about 100 times higher than that of histamine on a weight basis. Vascular permeability increasing activity of LTC4 was about 10 times higher than that of histamine, and LTD4 and PGE1 were also more potent than histamine. Increases of vascular permeability caused by histamine, serotonin, LTC4 and LTD4 were significantly potentiated by injecting 10(-6) g/ml of PGE1 simultaneously. Histamine-, serotonin- and LTC4-induced skin reactions in the mouse ear were suppressed significantly by the administrations of chlorpheniramine, methysergide and FPL 55712, respectively. In contrast, though chlorpheniramine and methysergide suppressed also mouse ear PCA (about 50 and 40%, respectively), neither FPL 55712, indomethacin nor BW 755C suppressed it. These results strongly suggest that the most important mediator involved in mouse ear PCA is histamine and that serotonin also plays an important role in the increase of vascular permeability caused by PCA. Despite their potent vascular permeability increasing activity LTC4, LTD4 and PGE1 do not seem to play an important role in mouse ear PCA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087885     DOI: 10.1159/000234067

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  9 in total

Review 1.  Immune regulation by phospholipase C-β isoforms.

Authors:  Wenbin Xiao; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

2.  Mast cell function is not altered by Coronin-1A deficiency.

Authors:  Sanja Arandjelovic; Dilki Wickramarachchi; Saskia Hemmers; Sunamita S Leming; Dwight H Kono; Kerri A Mowen
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

3.  Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.

Authors:  Wenbin Xiao; Jun-Ichi Kashiwakura; Hong Hong; Hiroki Yasudo; Tomoaki Ando; Mari Maeda-Yamamoto; Dianqing Wu; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

4.  Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy.

Authors:  Jun-chi Kashiwakura; Tomoaki Ando; Kenji Matsumoto; Miho Kimura; Jiro Kitaura; Michael H Matho; Dirk M Zajonc; Tomomitsu Ozeki; Chisei Ra; Susan M MacDonald; Reuben P Siraganian; David H Broide; Yuko Kawakami; Toshiaki Kawakami
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

5.  SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.

Authors:  Raja R Sivalenka; Manoj Sinha; Rolf Jessberger
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

Review 6.  Phospholipase C-β in immune cells.

Authors:  Toshiaki Kawakami; Wenbin Xiao
Journal:  Adv Biol Regul       Date:  2013-08-14

7.  Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b.

Authors:  Niko Föger; André Jenckel; Zane Orinska; Kyeong-Hee Lee; Andrew C Chan; Silvia Bulfone-Paus
Journal:  J Exp Med       Date:  2011-08-15       Impact factor: 14.307

8.  Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production.

Authors:  D Hata; Y Kawakami; N Inagaki; C S Lantz; T Kitamura; W N Khan; M Maeda-Yamamoto; T Miura; W Han; S E Hartman; L Yao; H Nagai; A E Goldfeld; F W Alt; S J Galli; O N Witte; T Kawakami
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

9.  Inhibition of IgE-dependent mouse triphasic cutaneous reaction by a boiling water fraction separated from mycelium of Phellinus linteus.

Authors:  Naoki Inagaki; Tomonori Shibata; Tomokazu Itoh; Tomohiro Suzuki; Hiroyuki Tanaka; Tomoyuki Nakamura; Yukihito Akiyama; Hirokazu Kawagishi; Hiroichi Nagai
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.